SRDX - SurModics - Biotech IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO

SRDX 27.57

-2.0%

Apr 17 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Lance Bredvold	4/27/2022 10:48:11 AM
	Read Replies (1) of 83

Finally selling below $40 after today's earnings report. I had expected the decline much earlier, but somehow optimism in the market as a whole caused the price to stay up despite poor expected earnings on the modified strategy. I'm mostly bothered by failure to report higher income since the idea was to hire their first 4 hot shot salesmen and that they would begin to increase sales. Yes, sales are up to $26mm now which is several mm. better than either last year or last quarter. But they surely don't knock my socks off. The market has had a major rout and yesterday we were down to about 87% of the S&P500 high (4175/4819) with SRDX showing little consistent weakness. The potential for 2022 is a loss of about $14mm to a small gain if the ABT surveil DCB gets premarket approval. Gary may be trending toward a little more promotional stand as he must defend his decision to, for the first time, borrow significant funds on their revolving credit facility as the attempt to become a device selling company. Like last quarter, I would like to buy but at a price well below today's. I suppose we could back off the aggressive sales move and go back to being consistently profitable on in vitro and progress payments, but that is unlikely. So, until the new strategy is proven, I expect the stock price to be weak--in fact, to decline from it's current highs. But again, I've found Gary's reports to be factual and sound, his leadership decisions wise, and I'll gamble that SRDX will eventually pull off the strategy he has undertaken.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next